Regencell Bioscience Holdings Ltd is 3.3x more valuable than Curaleaf Holdings, Inc. by market capitalization ($9.34 B vs $2.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RGC | CURLF |
|---|---|---|
| Market cap | $9.34 B | $2.85 B |
| US-listed rank | #983 | #1848 |
| Revenue (latest FY) | - | $1.27B |
| Net income (latest FY) | -$3.58M | -$231.07M |
| Net margin | - | -18.2% |
| SEC filings | 82 | 176 |
Regencell Bioscience Holdings Ltd is 3.3x more valuable than Curaleaf Holdings, Inc. by market capitalization ($9.34 B vs $2.85 B).
Full pages: Regencell Bioscience Holdings Ltd and Curaleaf Holdings, Inc., or browse the full rankings.